Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation TCT India 2025

Introduction to MyClip: Transcatheter Edge to Edge Repair System

Presenter: Anil Yadav & Viveka Kumar

July 27, 2025

Presentation THT 2025

Implantable Cardiac Patch Continuously Monitors Inflammation and Acute Heart Failure Biomarkers In Vivo and Ex Vivo

Presenter: Devleena Das

February 13, 2025

Presentation Controversies and Advances 2025

Changing ABO Blood Type During Ex Vivo Perfusion

Presenter: Fardad Esmailian

January 31, 2025

Presentation THT 2024

Ex Vivo Gene Therapy in Cardiac Allografts

Presenter: Dawn E. Bowles

March 06, 2024

Presentation THT 2024

Metabolic Modulation in Ex-Vivo Perfusion Models: Are We There Yet?

Presenter: Eduardo Rame

March 06, 2024

Presentation THT Abstracts 2024

Impact of obesity on different In-hospital outcomes after placement of left atrial appendage occlusion device (LAAOD)

Presenter: Vivek Jha

March 04, 2024

Presentation THT Abstracts 2024

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

Presenter: Rajiv Tayal

March 04, 2024

Presentation THT 2022

The Intersection Between EP and Heart Failure

Presenter: Vivek Reddy

February 02, 2022

Presentation TCT 2019

Rapid, Noninvasive Diagnostics for Aortic Stenosis and Heart Failure (Avicena Vivio)

Presenter: Maria Csete

September 26, 2019

Presentation TCT 2017

Can Alcohol Ablation Be Used to Treat Ventricular Tachycardia?

Presenter: John S. Douglas Jr, Valerian Fernandes, Vivek Y. Reddy

October 30, 2017

Presentation TCT 2014

Ex-Vivo Simulator for Training, Teaching, and Testing of Transcatheter Valve Therapies Based on the Principle of a Passive Beating Heart

Presenter: Devesh Amatya

September 16, 2014

Advertisement

Introduction to MyClip: Transcatheter Edge to Edge Repair System

Implantable Cardiac Patch Continuously Monitors Inflammation and Acute Heart Failure Biomarkers In Vivo and Ex Vivo

Changing ABO Blood Type During Ex Vivo Perfusion

Ex Vivo Gene Therapy in Cardiac Allografts

Metabolic Modulation in Ex-Vivo Perfusion Models: Are We There Yet?

Impact of obesity on different In-hospital outcomes after placement of left atrial appendage occlusion device (LAAOD)

Early Feasibility Study of the Vivasure PerQsealÆ Closure Device System After Use of the Impella Device for Cardiogenic Shock or Protected Percutaneous Coronary Intervention

The Intersection Between EP and Heart Failure

Rapid, Noninvasive Diagnostics for Aortic Stenosis and Heart Failure (Avicena Vivio)

Can Alcohol Ablation Be Used to Treat Ventricular Tachycardia?

Ex-Vivo Simulator for Training, Teaching, and Testing of Transcatheter Valve Therapies Based on the Principle of a Passive Beating Heart

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content